Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2007
03/14/2007CN1927176A Anticancer slow release comprising tetrazole violet and cytotoxic drug
03/14/2007CN1927175A Compound recipe anticancer slow release injection comprising tetrazole violet
03/14/2007CN1927174A Anticancer slow release injection loading tetrazole violet and potentiating agent thereof
03/14/2007CN1927173A Compound recipe anticancer slow release agent comprising tetrazole violet
03/14/2007CN1927172A Anticancer slow release agent comprising tetrazole violet and potentiating agent thereof
03/14/2007CN1927171A Anticancer slow release comprising tetrazole violet and cytotoxic drug
03/14/2007CN1927170A Anticancer slow release agent loading both newborn blood vessel and tetrazole violet
03/14/2007CN1927169A Norcantharidin magnetic nano microsphere and its preparing process
03/14/2007CN1927168A Implantation slow release medicine in eyes
03/14/2007CN1927165A Methanesulfonic acid pazufloxacin gel droplet for ear and its preparation
03/14/2007CN1304058C Water soluble paclitaxel prodrugs
03/14/2007CN1304056C Suspension-aid agent for vaccine of coccidiosis
03/14/2007CN1304055C Method for preparing embedded hydrophilic medicinal polymer minisphere or minisac carrier
03/14/2007CN1304052C Medicinal compositions for application to mucosa
03/14/2007CN1304048C Pharmaceutical compositions for oral delivery of pharmacologically active agents
03/14/2007CN1304011C Method for the protection of endothelial and epithclial cells during chemotherapy
03/14/2007CN1304006C Cosmetic or dermatological cream composition, the preparation and the use thereof
03/14/2007CN1304004C Local use medicinal composition
03/14/2007CN1304003C Colon positioning and adhering preparation and its preparing process
03/14/2007CN1304000C Use of valsartan in preparing drug for treating lung cancer
03/14/2007CN1303999C Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same
03/14/2007CN1303998C Pharmaceutical formulations containing darifenacin
03/14/2007CN1303993C Soft capsule preparation
03/14/2007CN1303992C Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
03/14/2007CN1303991C Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivative and process for preparing the same
03/14/2007CN1303986C Patch
03/14/2007CN1303985C Compositions comprising microparticles of water-insoluble substances and method for preparing same
03/14/2007CN1303983C Novel method of the manufacture of suppositories
03/14/2007CN1303982C Antifungal agent and preparation and use method
03/14/2007CN1303977C Pro-micelle pharmaceutical compositions
03/14/2007CA2558601A1 Substance carrier using hollow nanoparticle of hepatitis b virus protein and liposome, and method of introducing substance into cell
03/13/2007US7189808 Use of carboxy-terminal fragment of Ki-67 protein or of an active part, fragment or homologue thereof as compound that can be used for intracellular transfer and for introduction into and release by cells; antiinflammatory, anticancer agents
03/13/2007US7189757 Sleep disorders; side effect reduction
03/13/2007US7189705 Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
03/13/2007US7189689 Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders
03/13/2007US7189562 Mononuclear phagocytes in therapeutic drug delivery
03/13/2007US7189418 Method for extracting lipid mixture containing phospholipids comprising polyunsaturated fatty acids from viscera of fish, method for preserving viscera prior to extraction, and lipid mixture extracted thereby
03/13/2007US7189414 Erodible polymer matrix of a hydrogel polymer such as polycarbophil blended with a hydrophobic polymer, and a drug; improves bioavailability of a drug which is susceptible to enzymatic degradation by enzymes in the intestinal tract
03/13/2007US7189413 Drug delivery of proteins from polymeric blends
03/13/2007US7189412 Co-micronized with solid surfactant; contains lactose and magnesium stearate; mixture with binder and disintegrator; bioavailability
03/13/2007US7189411 Peptide/lipid complex formation by co-lyophilization
03/13/2007US7189395 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption
03/13/2007US7189393 Recombinant anti-tumor RNAse
03/13/2007US7189392 Osteogenic protein with hyaluronic acid for drug delivery and tricalcium phosphate
03/13/2007CA2420895C Method for treating erectile dysfunction and increasing libido in men
03/13/2007CA2376540C Process for preparing amlodipine benzenesulphonate
03/13/2007CA2355618C Polyol/oil suspensions for the sustained release of proteins
03/13/2007CA2273010C Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts
03/13/2007CA2272633C Polymer film compositions for capsules
03/13/2007CA2266581C Polymers containing polysaccharides such as alginates or modified alginates
03/13/2007CA2228078C Composition for oral administration containing pyridazinone compounds
03/13/2007CA2210038C Stabilized albumin-free recombinant factor viii preparation having a low sugar content
03/13/2007CA2184395C Effective dosage form for antiepileptic drugs
03/13/2007CA2176460C Method for dry blend compression of medicaments
03/13/2007CA2171111C Inhibition of urinary calculi growth
03/13/2007CA2167578C Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
03/08/2007WO2007027560A2 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents
03/08/2007WO2007027371A2 Method of removing medical adhesive
03/08/2007WO2007027187A1 Anti-inflammatory compositions and methods of use
03/08/2007WO2007027104A1 Animal medicament and method of manufature
03/08/2007WO2007026897A1 Oral composition for prevention or treatment of skin blemishes or freckles and food
03/08/2007WO2007026869A1 Antitumor agent
03/08/2007WO2007026864A1 Method for preparation of pharmaceutical composition having improved disintegradability
03/08/2007WO2007026772A1 Transgenic avian which has foreign gene containing sequence encoding feline-derived protein and method for production thereof
03/08/2007WO2007026771A1 Injection for intravenous drip
03/08/2007WO2007026755A1 Tablet for removal of tongue coating
03/08/2007WO2007026672A1 General-purpose electrolyte composition for iontophoresis
03/08/2007WO2007026645A1 Dieting composition comprising plant-derived essential oil as active ingredient, sheet-type dieting composition comprising the composition, transdermal pharmaceutical preparation for dieting, and methods for production of the preparation
03/08/2007WO2007026533A1 Soluble tablet containing nanosilicon particles and process for production thereof
03/08/2007WO2007026516A1 Novel drug delivery system
03/08/2007WO2007026247A1 Vaccines containing corynebacterium diphtheriae pili
03/08/2007WO2007026193A1 Solid state irradiation of hyaluronan-based solid preparations, its derivatives and mixtures in an unsaturated gaseous atmosphere and their use
03/08/2007WO2007026145A1 Prolonged release formulations comprising anastrozole
03/08/2007WO2007025988A2 Liquid formulations of pegylated growth hormone
03/08/2007WO2007025763A2 Highly cross-linked reagents for modifying biopharmaceuticals, production and use thereof
03/08/2007WO2007025715A1 Chitosan-silicon dioxide coprecipitate and use as excipient in solid dosage forms
03/08/2007WO2007025488A1 Method of production of fine-crystalline mixture containing non-steroid anti-inflammatory drug, fine-crystalline mixture obtainable by this method and solid pharmaceutical composition containing this mixture
03/08/2007WO2007025441A1 Polysaccharide microparticles containing biological agents: there preparation and applications
03/08/2007WO2007025388A2 Anti-apoptotic protein antibodies
03/08/2007WO2006134166A3 Pharmaceutical active ingredient for penetrating the blood-brain barrier combined with an active ingredient obtained from biogenic poisons to combat brain tumours
03/08/2007WO2006116076A3 Tab molecules
03/08/2007WO2006110819A3 Variant forms of urate oxidase and use thereof
03/08/2007WO2006110157A9 Nucleoside phosphonate conjugates as anti hiv agents
03/08/2007WO2006105741A3 Topical pharmaceutical formulation containing nimesulide
03/08/2007WO2006102108A3 Fucoidan compositions and methods for dietary and nutritional supplements
03/08/2007WO2006099537A3 The use of antibody-surrogate antigen systems for detection of analytes
03/08/2007WO2006084910A3 Device and method for treatment of dermatomycosis, and in particular onychomycosis
03/08/2007WO2006074451A3 Targeted chimeric molecules for cancer therapy
03/08/2007WO2006023207A3 Coacervate of anionic and cationic polymer forming microparticles for the sustained release of therapeutic agents
03/08/2007WO2005110486A3 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
03/08/2007WO2005079768A3 Amoxicillin instant granulate
03/08/2007US20070055013 Substrate and method of immobilizing protein
03/08/2007US20070055012 Coating system for sag resistant formaldehyde-free fibrous panels
03/08/2007US20070054879 Beta-chitin complex and method for producing the same
03/08/2007US20070054866 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
03/08/2007US20070054401 Composition for intracellular transport of biological particles or macromolecules
03/08/2007US20070054363 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders
03/08/2007US20070054284 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
03/08/2007US20070053988 Monodispersed solid lipid particle compositions
03/08/2007US20070053982 Sustained release oral formulations